Product Showcases and Satelitte Symposium


Product Showcases

Grifols USA Product Showcase

Date: Monday, March 16
Time: 11:00 –11:45 AM
Room: Grand Ballroom B

The Rabies Threat in the US and the Role of Postexposure Prophylaxis

This educational program will cover the prevalence of rabies in the US, pathogenesis, diagnosis, and most up-to-date treatment guidelines and best practices.

Presented by: Fredrick M. Abrahamian, DO, FACEP, FIDSA

Lunch provided to the first 125 attendees

Sponsored by:


Vapotherm Product Showcase

Date: Tuesday, March 17
Time: 7:00 – 7:45 AM
Room: Grand Ballroom B

No Mask. No Problem®. Mask-Free NIV™ for Spontaneously Breathing Patients

Dr. Sharma will discuss the current research, mechanisms of action and applications of High-Velocity Nasal Insufflation (HVNI) as a mask-free noninvasive ventilation solution for patients in respiratory distress.

Presented by: Kunal Sharma, MD, CMQ, Board Certified Emergency Medicine Provider, Houston, TX

Breakfast provided to the first 75 attendees

Sponsored by:


Bristol-Myers Squibb and Pfizer Alliance Product Showcase

Date: Thursday, March 19
Time: 7:00 – 7:45 AM
Room: Grand Ballroom B

Challenges of treating deep vein thrombosis (DVT) and pulmonary embolism (PE) in the hospital and after discharge

Presented by:Trevor Cummings, MD, Emergency Care Specialists, Director of Observation Services and Cardiovascular Liaison at Spectrum Health

Breakfast provided to the first 75 attendees

Sponsored by:


Eagle Pharmaceuticals Product Showcase

Date: Friday, March 20
Time: 7:00 – 7:45 AM
Room: Grand Ballroom B

Clinical Insights into Exertional Heat Stroke (EHS), a Case-Based Presentation

Exertional Heat Stroke (EHS) is a severe form of heat illness and is a medical emergency that can result in organ damage or even death. EHS can affect anyone, regardless of age or physical ability, and most often occurs when people engage in physical activities in hot or humid environments. Athletes of all ages and levels are at risk for EHS, often with dire consequences. What many people don’t know is that EHS is considered the third leading cause of death in high school athletes. Learn more about this condition from Dr. Mike Greenberg so that you can be prepared to recognize and diagnose patients with EHS.

Presented by: Mike Greenberg, MD

Breakfast provided to the first 75 attendees

Sponsored by:

EAGLE Logo_Blue_RGB.jpg


Satellite Symposium

This CME symposium is not a part of the official 2020 SEMPA 360 educational program as planned by SEMPA’s Education Committee.

Date: Wednesday, March 18
Time: 6:30 – 7:45 AM
Room: Grand Ballroom B

Clinical Pearls for Advanced Practice Providers: Reversing Direct Oral Anticoagulants in the Emergency Department

The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. While DOACS are associated with a lower incidence of major bleeding compared with vitamin K antagonists, it remains imperative for emergency medicine physician assistants to better understand how to assess and manage patients who present with life-threatening or uncontrolled bleeding or who require urgent surgery. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event. This ACEP/Spire Learning CME breakfast meeting at SEMPA 360 will offer clinical pearls for the assessment of bleeding severity in patients receiving DOACs; expert-guided insights into the rapid reversal of DOAC-associated bleeding; and practical strategies for aligning clinical practice with local hospital bleeding management protocols.

Learning Objectives:

Upon completion of this activity, learners will be better able to:

  • RECOGNIZE the signs and symptoms of major bleeding in patients receiving DOAC therapy
  • IDENTIFY appropriate assays to measure anticoagulant activity in patients receiving DOAC therapy
  • SELECT a reversal strategy based on the type of anticoagulant, dose, timing of last dose, severity of bleeding, and indication
  • UTILIZE local protocols for evaluating patients and managing DOAC-associated bleeding

Presented by:

Colin G. Kaide, MD, Associate Professor of Emergency Medicine, Wexner Medical Center at The Ohio State University, Columbus, OH

Eric W. Cucchi MS, PA-C, DFAAPA, Director of eICU Operations, Instructor of Nursing, Graduate School of Nursing; Chair, AP Council; Staff Physician Assistant, Critical Care Unit, Memorial Campus, UMass Memorial Medical Center, eICU Support Center, Hahnemann Campus

This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.

Sponsors

Virtual SEMPA20

Virtual SEMPA Speaker

Get access to the slides and synchronized audio from all the lectures that can viewed on your phone, tablet and laptop whenever and wherever you want or need. The perfect complement to your SEMPA 360 conference experience.

Virtual SEMPA  

4950 W. Royal Lane, Irving, TX 75063-2524 844-381-0911
© 2019 Society of Emergency Medicine Physician Assistants Contact UsPrivacy Policy